Pharmaceutical conspiracy

Drug giants Johnson & Johnson and Novartis colluded to delay the availability of a less expensive generic version of a powerful medication often used to ease severe pain in cancer patients. EU antitrust chief said on Thursday that the money probably changed hands to keep lower-cost versions of the drug off the market in the Netherlands and that is illegal when it involves a payment from the brand-name company to the generic company.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: